Stealth Merger: Drug Companies and Medical Research at NIH – LAT Sun, 7 Dec 2003 Los Angeles Times reporter, David Willman, who twice won the Pulitzer Prize (1994, 2001) has once again demonstrated what fine investigative journalism is about. His investigative series in 2000 put the spotlight on conflicts of…
Debate: Ethics of Surgically Implanting Drug Device in psychiatric patients Wed, 5 Nov 2003 An AHRP Infomail (October 7, 2003) criticizing the ethics of University of Pennsylvania’s planned surgical “drug implant” experiment in psychiatric patients, prompted a debate between AHRP president, Vera Sharav, and bioethicist, Paul Root Wolpe, Ph.D., University…
Fast for Freedom: A debate (of sorts) about scientific evidence Sat, 23 Aug 2003 The Medical Director of the APA was unable to cite a single scientific study proving an underlying biochemical basis for any mental illness. An amazing exchange between Dr. James Scully and a panel of experts lays…
Comments submitted by The Alliance for Human Research Protection Re: Best Pharmaceuticals for Children’s Act of 2002 The National Academy of Sciences Committee of the Institute of Medicine on Clinical Research Involving Children August 18, 2003 Vera Hassner Sharav, President John H. Noble, Jr., Ph.D, Treasurer David Cohen, Ph.D, Secretary…
AHRP has been closely monitoring pediatric research trends since passage of the FDA Modernization Act of 1997. We believe that medications used in children should be thoroughly tested for safety, effectiveness and appropriate dose. But unlike adults who can exercise their autonomous right to informed consent, children who are enrolled in clinical trials are non-consensual human subjects. They should not, therefore, be made to assume the burden of testing possibly toxic drugs whose safety is unknown.
Infomail Archive 2003 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 19, 2003: Eli Lilly Prozac UK Fact Sheet: “Not Recommended” for Children – PMDD Withdrawn in UK Dec 19, 2003: Not-So-Public-Relations: Drug Industry & Bioethics – is it casuistry or sophistry? Dec 18, 2003:…
References for THE IMPACT OF THE FDA MODERNIZATION ACT ON THE RECRUITMENT OF CHILDREN FOR RESEARCH Vera Hassner Sharav Published in ETHICAL HUMAN SCIENCES & SERVICES Summer 2003, vol. 5 pp. 83-108 Agency for Health Care Research & Quality. (1999). Treatment of attention-deficit/hyperactivity disorder: Summary, evidence Report / Technology assessment…
Infomail Archive – Pre 2003 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav December 28, 2002: Will 2 to 5 year old Amer. kids be exposed to Smallpox Vaccine? Israeli Intelligence says “No immediate threat” December 24, 2002: Moral turpitude: Herpes experiment surpasses Tuskegee December 20,…
FDA approves anti-psychotic, clozapine, to treat suicide December 20, 2002 The first of the so-called atypical antipsychotic drugs, clozapine (Clozaril), has been approved by the FDA as a treatment against suicide in patients with schizophrenia. The drug has been hailed as a miracle for some, but deadly for others. The…
November 08, 2002 Investigative series finds kids drugged without cause – Journal News The Journal News, a regional NYS newspaper conducted a three month investigation of residential treatment centers (RTC) for troubled children in NYS. The findings reported in a 7-part investigative series show “a pattern of increasing use” of…
Documents Show Drug Company Promotion of Unproven Drug_NYT Tue, 29 Oct 2002 Internal company documents unsealed in a federal lawsuit reveal how the unholy alliance between doctors and drug companies has corrupted medical practice and defrauded the US taxpayer. Although it is illegal for drug companies to promote a drug…
Subject: Kids are “hot ticket” in Rx drug market Date: Thu, 19 Sep 2002 17:39:52 -0400 According to MEDCO Health, which manages prescription drug plans, the records of 500,000 children under age 19 reveal that: “Kids have surpassed senior citizens as the hot ticket in the prescription drug market… Spending…
